Olink®Part of Thermo Fisher Scientific
Powerful, NGS-based proteomics - effortlessly uncover meaningful insights
A unique combination of specificity and scalability enables high-throughput, multiplex protein biomarker analysis.
Next-generation high-throughput proteomics empowers genetically-informed assessment of protein causality and the confident identification of novel drug targets.
Join the growing global community and consortia of Olink users to empower your biomarker discovery.
Over 3,800 and growing rapidly – covering all major disease areas
Your source for Olink’s terms, privacy policies, and compliance details
Filters
Medicine, 2026Circulating cytokines mediate the risk of COPD: A mediation analysis based on 473 gut microbiota and 91 circulating cytokines
Jiang Q., Shen W., Liu X. et al.
Olink Target 96
International Journal of Radiation Oncology*Biology*Physics, 2026A New Predictive Model for Radiation Necrosis Risk based on PTV-enriched Blood Inflammatory Biomarkers in Patients with Brain Metastases Treated with Stereotactic Radiosurgery
Jablonska P., Serrano D., Galán N. et al.
Mucosal Immunology, 2026Autoantibodies induced by Mycoplasma pneumoniae infection underlie the severity of acute lung injury in children
Huang H., Yuan X., Li S. et al.
Journal of Allergy and Clinical Immunology, 2026IL-31 blockade elevates thymus and activation-regulated chemokine by lifting LAMP3+CD1c+ mature dendritic cells from calcitonin gene–related peptide–calcitonin receptor–like neuroimmune suppression in atopic dermatitis
Honryo A., Masuda T., Nakamizo S. et al.
Olink Explore HT
Communications Medicine, 2026Adhesion molecules provide an endothelial protein signature in preclinical and clinical Alzheimer’s disease and predict clinical progression
Hajjar I., Neal R., Singh N. et al.
Hepatology Communications, 2026CD8 TRM-like T cells expressing perforin and IFN-γ define a pediatric activated T-cell acute liver failure endotype
Diamond T., Chapin C., Diorio C. et al.
Olink Explore 3072/384
Nature Medicine, 2026A deep joint-learning proteomics model for diagnosis of six conditions associated with dementia
An L., Pichet Binette A., Hristovska I. et al.
npj Cardiovascular Health, 2026Berberine signature and cardiometabolic diseases using randomized controlled trial, cohort study and Mendelian randomization
Zhao J., Sarsani V., Chen B. et al.
Journal of Affective Disorders, 2026Multi-omics analysis reveals CXCL14+ inhibitory neuron dysfunction in major depressive disorder
Zhang L., Duan H., Lyu H. et al.
Journal of Neuroinflammation, 2026Microglial NCAM1 attenuates ischemic brain injury by inhibiting NF-κB-driven neuroinflammation through IκBα stabilization
Yu Z., Yu L., Lu W. et al.
Calcified Tissue International, 2026A Large-Scale Multi-omics Polygenic Risk Score Analysis Identified Candidate Biomarkers Associated with Heel Bone Mineral Density
Yang X., Liu H., Xu K. et al.
Respiratory Research, 2026Plasma proteomic and machine learning models for differentiating idiopathic pulmonary fibrosis and connective tissue disease–associated interstitial lung disease: findings from a prospective cohort
Wu C., Lai D., Chen Y. et al.
Clinical Proteomics, 2026Evaluation of the relationship between inflammation and typical chest pain in ST-elevation myocardial infarction
Wolfermann S., Schmitz T., Raake P. et al.
Frontiers in Immunology, 2026Elevated IL-17A level is associated with poor overall survival following immune checkpoint inhibitors combined with targeted therapy in hepatocellular carcinoma with hyperbilirubinemia
Wang J., Pan S., Xiong C. et al.
Nature, 2026Immune evasive DNA donors and recombinases license kilobase-scale writing
Tou C., Xie K., Ferreira da Silva J. et al.
Olink Target 48 Mouse
Naunyn-Schmiedeberg's Archives of Pharmacology, 2026Constructing a protein–protein interaction network for autoimmune liver diseases by integrating pQTL, rQTL, and mediation analyses
Tian D., Yang Z., Zhao L. et al.
Journal of Alzheimer's Disease Reports, 2026Exploring potential genetic correlation and causality between cathepsins and neurodegenerative diseases: Insight from Mendelian randomization analyses
Shu H., He R., Zhu Z. et al.
Signal Transduction and Targeted Therapy, 2026Distinct metabolomic and proteomic signatures in Parkinson’s disease patients with REM sleep behavior disorder
Shao Y., Wang J., Liu Y. et al.
International Journal of Cancer, 2026 ULK4 and CDKN2A polymorphisms influence the risk of developing monoclonal gammopathy of undetermined significance
Sánchez‐Maldonado J., Macauda A., Cabrera‐Serrano A. et al.
Frontiers in Immunology, 2026HERV-W association with serum biomarkers NfL and GFAP in multiple sclerosis
Ruberto S., Dominguez-Mozo M., Villar L. et al.
Olink Target 48
3821 publications
Items per page
61-80 of 3821 publications